Article

Validation of a NGS panel, with automated analysis, designed for detection of medically actionable tumor biomarkers for Latin America

2021-03-20

Abstract excerpt

The genomic characterization of solid tumors and a rapidly growing repertoire of target drugs are revolutionizing cancer treatment. Next-generation sequencing (NGS) panels are progressively used in clinical practice for target therapy in high-income countries. In contrast, limited access to tumor sequencing, among other barriers, precludes precision cancer treatment in low- and middle-income countries. To build to...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7035d0a3-cfd8-505c-b0f5-c00ce7d0527c
DOI: 10.1101/2021.03.19.21253988

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Validation of a NGS panel, with automated analysis, designed for detection of medically actionable tumor biomarkers for Latin AmericaDOI 10.1101/2021.03.19.21253988Read

Clinical Tumor Sequencing: Opportunities and Challenges for Precision Cancer MedicineSemantic proximity Read

Multi-laboratory proficiency testing of clinical cancer genomic profiling by next-generation sequencing.Semantic proximity Read

Effective quality management practices in routine clinical next-generation sequencingSemantic proximity Read

Clinical Validation of Whole Genome Sequencing for Cancer Diagnostics.Semantic proximity Read

High-throughput detection of clinically targetable alterations using next-generation sequencing.Semantic proximity Read

Actionable mutational profiling in solid tumors using hybrid-capture-based next-generation sequencing in a real-world setting in Spain.Semantic proximity Read

Analytical demands to use whole-genome sequencing in precision oncologySemantic proximity Read

Molecular tests and target therapies in oncology: recommendations from the Italian workshop.Semantic proximity Read

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies.Semantic proximity Read

Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies.Semantic proximity Read

Validation of a next-generation sequencing assay for clinical molecular oncology.Semantic proximity Read

Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical OncologySemantic proximity Read